chronic medication core formulary effective 1 january …

47
1 CHRONIC MEDICATION CORE FORMULARY Effective 1 January 2011 This formulary represents drugs covered for chronic use for 25 Chronic Disease List (CDL) conditions and individual Diagnosis and Treatment Pairs (DTP) conditions where applicable for each scheme. Reimbursement of medicines for non-CDL and non-DTP conditions is subject to Fund Rules and Qualsa Medicine Reimbursement Policy. Unless stipulated, all active ingredients listed in this formulary are subject to the Qualsa Maximum Price (QMP). The examples below serve as a guide on the trade names available for the active ingredients listed and not for marketing a specific brand. Any product within the QMP category may be used, however a co-payment may be attracted if the product selected is above the generic reference threshold. The dispensing pharmacist may make a generic substitution to assist members in avoiding a co-payment. Treatment designated as “Accepted treatment” indicates that this is a medicine covered as first line, according to the Qualsa Medicine Reimbursement Policy. For treatment designated as “Motivation required”, certain criteria as specified in the Qualsa Medicine Reimbursement Policy should be met. For treatment designated as “special investigation”, the relevant clinical investigation reports as specified in the Qualsa Medicine Reimbursement Policy are required. Abbreviations of dosage form CAP Capsule ENE Enema OPD Eye drops SYR Syrup CPS Capsule (Inhaler) INH Inhaler SLN Sublingual TAB Tablet CRM Cream INJ Injection SRC Slow release capsule UNG Ointment DRP Drops LOT Lotion SRT Slow release tablet DSP Dispersable NAS Nasal spray SUP Suppository ECT Enteric-coated tablet NOD Nasal drops SUS Suspension INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT Addison's disease Corticosteroids, oral Fludrocortisone acetate 0.1mg TAB Florinef acetate Motivation required Hydrocortisone 10mg TAB Covocort Accepted treatment Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment Prednisone 5mg TAB Be-tabs prednisone Panafcort Trolic Accepted treatment

Upload: others

Post on 02-Oct-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

1

CHRONIC MEDICATION CORE FORMULARY Effective 1 January 2011

• This formulary represents drugs covered for chronic use for 25 Chronic Disease List (CDL) conditions and individual Diagnosis and Treatment Pairs (DTP) conditions where applicable for each scheme.

• Reimbursement of medicines for non-CDL and non-DTP conditions is subject to Fund Rules and Qualsa Medicine Reimbursement Policy.

• Unless stipulated, all active ingredients listed in this formulary are subject to the Qualsa Maximum Price (QMP).

• The examples below serve as a guide on the trade names available for the active ingredients listed and not for marketing a specific brand. Any product within the QMP category may be used, however a co-payment may be attracted if the product selected is above the generic reference threshold.

• The dispensing pharmacist may make a generic substitution to assist members in avoiding a co-payment.

• Treatment designated as “Accepted treatment” indicates that this is a medicine covered as first line, according to the Qualsa Medicine Reimbursement Policy.

• For treatment designated as “Motivation required”, certain criteria as specified in the Qualsa Medicine Reimbursement Policy should be met.

• For treatment designated as “special investigation”, the relevant clinical investigation reports as specified in the Qualsa Medicine Reimbursement Policy are required.

Abbreviations of dosage form CAP Capsule ENE Enema OPD Eye drops SYR Syrup CPS Capsule (Inhaler) INH Inhaler SLN Sublingual TAB Tablet CRM Cream INJ Injection SRC Slow release capsule UNG Ointment DRP Drops LOT Lotion SRT Slow release tablet DSP Dispersable NAS Nasal spray SUP Suppository ECT Enteric-coated tablet NOD Nasal drops SUS Suspension

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Addison's disease

Corticosteroids, oral

Fludrocortisone acetate 0.1mg TAB Florinef acetate Motivation required

Hydrocortisone 10mg TAB Covocort Accepted treatment

Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment

Prednisone 5mg TAB Be-tabs prednisone Panafcort Trolic Accepted treatment

Page 2: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

2

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Asthma

Beta agonists, short-acting

Salbutamol 100mcg INH Venteze Asthavent Accepted treatment

Salbutamol 2.5mg SLN Ventolin nebules Motivation required

Salbutamol 200mcg CPS Asthavent Accepted treatment

Salbutamol 200mcg CPS Ventodisks Accepted treatment

Salbutamol 400mcg CPS Ventodisks Motivation required

Fenoterol INH Berotec HFA Accepted treatment

Fenoterol and ipratropium bromide

50mcg/20mcg INH Duovent HFA Motivation required

Beta agonists, long-acting

Formoterol 12mcg CPS Foratec DP caps Accepted treatment

Formoterol 9mcg INH Oxis Accepted treatment

Salmeterol 25mcg INH Serevent Accepted treatment

Salmeterol 50mcg INH Serevent Accepted treatment

Corticosteroids, inhaled

Beclometasone 100mcg INH Beclate Accepted treatment

Beclometasone 200mcg INH Beclate Accepted treatment

Beclometasone 50mcg INH Beclate Accepted treatment

Budesonide 100mcg INH/CPS Inflacor Budeflam Inflammide Accepted treatment

Budesonide 200mcg INH/CPS Inflacor Budeflam Inflammide Accepted treatment

Budesonide 400mcg INH/CPS Inflacor Inflammide Novoliser Accepted treatment

Corticosteroids, oral

Prednisolone 15mg/5ml SYR Preflam Motivation required

Prednisone 5mg/ml SYR Pulmison paed Motivation required

Corticosteroids and beta agonists, long-acting

Budesonide and formoterol 160mcg/4.5mcg INH Symbicord Motivation required

Budesonide and formoterol 320mcg/9mcg INH Symbicord Motivation required

Budesonide and formoterol 80mcg/4.5mcg INH Symbicord Motivation required

Salmeterol and fluticasone 25mcg/125mcg INH Sereflo Seretide Accepted treatment

Salmeterol and fluticasone 25mcg/250mcg INH Sereflo Seretide Accepted treatment

Salmeterol and fluticasone 25mcg/50mcg INH Sereflo Seretide Accepted treatment

Salmeterol and fluticasone 50mcg/100mcg INH Foxair Seretide Accepted treatment

Salmeterol and fluticasone 50mcg/250mcg INH Foxair Seretide Accepted treatment

Page 3: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

3

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Salmeterol and fluticasone 50mcg/500mcg INH Foxair Seretide Accepted treatment

Xanthines

Aminophylline 225mg SRT Phyllocontin Accepted treatment

Theophylline SYR Alcophyllin Nuelin liquid Motivation required

Theophylline 200mg SRT Sandoz Theophylline Accepted treatment

Theophylline 250mg SRT Nuelin SA Accepted treatment

Theophylline 300mg SRT Sandoz Theophylline Accepted treatment

Theophylline 400mg SRT Uniphyl Accepted treatment

Theophylline 600mg SRT Uniphyl Accepted treatment

Bipolar mood disorder

Heterocyclic antidepressants

Amitriptyline 25mg TAB Trepiline Sandoz-amitriptyline Accepted treatment

Dothiepin (dosulepin) 25mg CAP Thaden Sandoz-dothiepin Accepted treatment

Dothiepin (dosulepin) 75mg TAB Thaden Sandoz-dothiepin Accepted treatment

Imipramine 25mg TAB Ethipramine Accepted treatment

Maprotiline 25mg TAB Ludiomil Motivation required

Maprotiline 75mg TAB Ludiomil Motivation required

Selective serotonin receptor inhibitors

Citalopram 10mg TAB Austell-citalopram Accepted treatment

Citalopram 20mg TAB Austell-citalopram Citalopram-Winthrop Sandoz-citalopram Accepted treatment

Citalopram 40mg TAB Austell-citalopram Citalopram-Winthrop Depramil Accepted treatment

Fluoxetine 20mg CAP/TAB A-lennon fluoxetine Zydus-fluoxetine Ranflocs Accepted treatment

Fluoxetine 40mg DSP Prohexal T Motivation required

Other

Sulpiride 200mg TAB Bio-sulpiride Motivation required

Sulpiride 25mg SYR Eglonyl Motivation required

Sulpiride 50mg CAP Espiride Sandoz Sulpiride Motivation required

Mood stabilisers

Lithium 250mg TAB Camcolit Accepted treatment

Lithium 400mg TAB Camcolit Accepted treatment

Lithium 450mg TAB Quilonum Retard Accepted treatment

Carbamazepine 200mg TAB/SRT Sandoz Carbamazepine CR Degranol CPL-carbamazepine Accepted treatment

Carbamazepine 400mg SRT Sandoz Carbamazepine CR Accepted treatment

Lamotrigine 100mg TAB Aspen-lamotrigine Lamitor Dyna-Lamotrigine Accepted treatment

Page 4: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

4

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Lamotrigine 200mg TAB Lamidus Austell-lamotrigine Dyna-Lamotrigine Accepted treatment

Lamotrigine 25mg TAB Aspen-lamotrigine Lamitor Dyna-Lamotrigine Accepted treatment

Lamotrigine 50mg TAB Aspen-lamotrigine Lamitor Dyna-Lamotrigine Accepted treatment

Valproic acid 150mg CAP/SRT Convulex Epilim Accepted treatment

Valproic acid 200mg SRT Epilim Accepted treatment

Valproic acid 300mg CAP Convulex Accepted treatment

Valproic acid 500mg CAP/SRT Convulex Epilim Accepted treatment

Valprioc acid 200mg/5ml SYR Epilim Motivation required

Antipsychotics

Chlorpromazine 100mg TAB Largactil Accepted treatment

Chlorpromazine 25mg TAB Largactil Accepted treatment

Chlorpromazine 50mg TAB Largactil Accepted treatment

Haloperidol 0.5mg CAP Serenace Accepted treatment

Haloperidol 1.5mg TAB Sandoz Haloperidol Accepted treatment

Haloperidol 10mg TAB Serenace Accepted treatment

Haloperidol 5mg TAB Serenace Sandoz Haloperidol Accepted treatment

Trifluoperazine 1mg TAB Stelazine Accepted treatment

Trifluoperazine 5mg TAB Stelazine Accepted treatment

Zuclopenthixole 10mg TAB Clopixol Motivation required

Zuclopenthixole 2mg TAB Clopixol Motivation required

Bronchiectasis

Antibiotic treatment will be reimbursed subject to Qualsa Medicine Policy and specific organism sensitivity.

Cardiomyopathy/Heart failure

Aspirin

Acetylsalicylic acid 100mg TAB Bayer aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf aspirin Be-tabs aspirin Aspirin (Resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Anticoagulants

Warfarin 1mg TAB Cipla-warfarin Accepted treatment

Warfarin 3mg TAB Cipla-warfarin Accepted treatment

Warfarin 5mg TAB Cipla-warfarin Lennon warfarin Accepted treatment

Page 5: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

5

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Diuretics

Furosemide 10mg/ml SYR Lasix Oral Motivation required

Furosemide 40mg TAB Diuresix Mylan-furosemide Beuresis Accepted treatment

Hydrochlorothiazide 12.5mg TAB Ridaq Accepted treatment

Hydrochlorothiazide 25mg TAB Hexazide Ridaq Accepted treatment

Hydrochlorothiazide and amiloride

25mg/2.5mg TAB Amiloretic HS Accepted treatment

Hydrochlorothiazide and amiloride

50mg/5mg TAB Amiloretic Spec-Co-Amiloride Betaretic Accepted treatment

Indapamide 2.5mg TAB Cipla-Indapamide Daptril Mylan-indapamide Accepted treatment

Spironolactone 100mg TAB Spiractin Accepted treatment

Spironolactone 25mg TAB Spiractin Sandoz Spironolactone Accepted treatment

Triamterine and hydrochlorothiazide

50mg/25mg TAB Renezide Accepted treatment

Hydrochlorothiazide and potassium

50mg/300mg TAB Urirex K Accepted treatment

Potassium supplements

Potassium chloride 600mg TAB Plenish-K Sandoz K-600 Accepted treatment

ACE-inhibitors and combinations

Captopril 12.5mg TAB Captohexal Accepted treatment

Captopril 25mg TAB Captohexal Mylan-captopril Bio-captopril Accepted treatment

Captopril 50mg TAB Captohexal Mylan-captopril Zapto Accepted treatment

Enalapril 10mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 2.5mg TAB Renitec Accepted treatment

Enalapril 20mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 5mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Lisinopril 10mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 2.5mg TAB Austell-lisinopril Accepted treatment

Lisinopril 20mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 5mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Perindopril 4mg TAB Prexum Vectoryl Cipla-perindopril Accepted treatment

Perindopril 8mg TAB Vectoryl Cipla-perindopril Accepted treatment

Perindopril 10mg TAB Prexum Coversyl Accepted treatment

Ramipril 1.25mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 10mg CAP Austell-ramipril Ran-ramipril Rampil Motivation required

Ramipril 2.5mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 5mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Page 6: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

6

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Trandolapril 0.5mg CAP Mavik Accepted treatment

Trandolapril 2mg CAP Mavik Accepted treatment

Captopril and diuretic 50mg/25mg TAB Captoretic Zapto-Co Capozide Accepted treatment

Enalapril and diuretic 12.5mg TAB Enap Co Pharmapress Co Accepted treatment

Lisinopril and diuretic 10mg/12.5mg TAB Lisoretic Lisozide Hexal-lisinopril Co Accepted treatment

Lisinopril and diuretic 20mg/12.5mg TAB Lisoretic Zestozide Hexal-lisinopril Co Accepted treatment

Perindopril and indapamide 4mg/1.5mg TAB Prexum Plus Vectoryl Plus Accepted treatment

Angiotensin receptor blockers and combinations

Losartan 50mg TAB Lepitrin Cipla-losartan Los-arb Accepted treatment

Losartan 100mg TAB Zartan Cipla-losartan Accepted treatment

Valsartan 160mg TAB Tareg Motivation required

Valsartan 320mg TAB Diovan Motivation required

Valsartan 40mg TAB Diovan Motivation required

Valsartan 80mg TAB Tareg Motivation required

Losartan and diuretic 100mg/25mg TAB Fortzaar Accepted treatment

Losartan and diuretic 50mg/12.5mg TAB Cozaar Comp Accepted treatment

Valsartan and diuretic 160mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretic 160mg/25mg TAB Co-diovan Plus Motivation required

Valsartan and diuretic 320mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretic 320mg/50mg TAB Co-diovan Motivation required

Valsartan and diuretic 80mg/12.5mg TAB Co-tareg Motivation required

Calcium channel blockers

Amlodipine 10mg TAB Almadin Ciplavasc Amlate Accepted treatment

Amlodipine 5mg TAB Almadin Ciplavasc Amlate Accepted treatment

Felodipine 10mg SRT Felodipine-hexal Accepted treatment

Felodipine 5mg SRT Felodipine-hexal Accepted treatment

Beta blockers and combinations

Atenolol 100mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 25mg TAB Tenopress Accepted treatment

Atenolol 50mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Bisoprolol 10mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Bisoprolol 2.5mg TAB Cardicor Accepted treatment

Bisoprolol 5mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Propranolol 10mg TAB Indoblok Prodorol Purbloka Accepted treatment

Page 7: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

7

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Propranolol 40mg TAB Indoblok Prodorol Purbloka Accepted treatment

Atenolol and other diuretics 100mg/25mg TAB Sandoz Co-tenidone Tenchlor Adco-loten Accepted treatment

Atenolol and other diuretics 50mg/12.5mg TAB Sandoz Co-tenidone Tenchlor HS Accepted treatment

Alpha/beta blockers

Carvedilol 12.5mg TAB Carloc Carvetrend Vediblok Accepted treatment

Carvedilol 25mg TAB Carloc Carvetrend Vediblok Accepted treatment

Carvedilol 6.25mg TAB Carloc Carvetrend Vediblok Accepted treatment

Vasodilators

Hydralazine 10mg TAB Hyperphen Accepted treatment

Hydralazine 25mg TAB Sandoz Hydralazine Accepted treatment

Hydralazine 50mg TAB Hyperphen Sandoz Hydralazine Accepted treatment

Cardiac glycosides

Digoxin 0.05mg/ml SYR Lanoxin Paed Accepted treatment

Digoxin 0.0625mg TAB Lanoxin Accepted treatment

Digoxin 0.25mg TAB Lanoxin Purgoxin Accepted treatment

Organic nitrates

Isosorbide dinitrate 10mg TAB Sandoz Isosorbide dinitrate Accepted treatment

Isosorbide dinitrate 30mg TAB Sandoz Isosorbide Accepted treatment

Isosorbide dinitrate 40mg TAB Isordil Tembid Accepted treatment

Isosorbide dinitrate 5mg TAB Sandoz Isosorbide dinitrate Accepted treatment

Chronic obstructive pulmonary disease

Beta agonists, short-acting

Salbutamol 100mcg INH Venteze Asthavent Accepted treatment

Salbutamol 2.5mg SLN Ventolin nebules Motivation required

Salbutamol 200mcg CPS Asthavent Accepted treatment

Salbutamol 200mcg CPS Ventodisks Accepted treatment

Salbutamol 400mcg CPS Ventodisks Motivation required

Fenoterol INH Berotec HFA Accepted treatment

Ipratropium bromide and salbutamol

20mcg/100mcg INH Combivent Motivation required

Anticholinergics, inhaled

Ipratropium bromide 40mcg INH Ipvent Accepted treatment

Corticosteroids, inhaled

Beclometasone 100mcg INH Beclate Special investigations

Page 8: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

8

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Beclometasone 200mcg INH Beclate Special investigations

Beclometasone 50mcg INH Beclate Special investigations

Budesonide 100mcg INH/CPS Inflacor Budeflam Inflammide Special investigations

Budesonide 200mcg INH/CPS Inflacor Budeflam Inflammide Special investigations

Budesonide 400mcg INH/CPS Inflacor Inflammide Novoliser Special investigations

Corticosteroids and beta agonists, long-acting

Salmeterol and fluticasone 25mcg/125mcg INH Sereflo Seretide Special investigations

Salmeterol and fluticasone 25mcg/250mcg INH Sereflo Seretide Special investigations

Salmeterol and fluticasone 25mcg/50mcg INH Sereflo Seretide Special investigations

Salmeterol and fluticasone 50mcg/100mcg INH Foxair Seretide Special investigations

Salmeterol and fluticasone 50mcg/250mcg INH Foxair Seretide Special investigations

Salmeterol and fluticasone 50mcg/500mcg INH Foxair Seretide Special investigations

Xanthines

Aminophylline 100mg TAB Norstan-ted Accepted treatment

Aminophylline 200mg TAB Norstan-ted Accepted treatment

Aminophylline 225mg SRT Phyllocontin Accepted treatment

Theophylline SYR Alcophyllin Nuelin liquid Accepted treatment

Theophylline 200mg SRT Sandoz Theophylline Accepted treatment

Theophylline 250mg SRT Nuelin SA Accepted treatment

Theophylline 300mg SRT Sandoz Theophylline Accepted treatment

Theophylline 400mg SRT Uniphyl Accepted treatment

Theophylline 600mg SRT Uniphyl Accepted treatment

Chronic renal failure

Diuretics

Furosemide 10mg/ml SYR Lasix Oral Motivation required

Furosemide 40mg TAB Diuresix Mylan-furosemide Beuresis Accepted treatment

Hydrochlorothiazide 12.5mg TAB Ridaq Accepted treatment

Hydrochlorothiazide 25mg TAB Hexazide Ridaq Accepted treatment

Hydrochlorothiazide and amiloride

25mg/2.5mg TAB Amiloretic HS Accepted treatment

Hydrochlorothiazide and amiloride

50mg/5mg TAB Amiloretic Spec-Co-Amiloride Betaretic Accepted treatment

Indapamide 2.5mg TAB Cipla-Indapamide Daptril Mylan-indapamide Accepted treatment

Spironolactone 100mg TAB Spiractin Accepted treatment

Triamterine and hydrochlorothiazide

50mg/25mg TAB Renezide Accepted treatment

Page 9: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

9

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Hydrochlorothiazide and potassium

50mg/300mg TAB Urirex K Accepted treatment

Potassium supplements

Potassium chloride 600mg TAB Plenish-K Sandoz K-600 Accepted treatment

ACE inhibitors and combinations

Captopril 12.5mg TAB Captohexal Accepted treatment

Captopril 25mg TAB Captohexal Mylan-captopril Bio-captopril Accepted treatment

Captopril 50mg TAB Captohexal Mylan-captopril Zapto Accepted treatment

Enalapril 10mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 2.5mg TAB Renitec Accepted treatment

Enalapril 20mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 5mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Lisinopril 10mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 2.5mg TAB Austell-lisinopril Accepted treatment

Lisinopril 20mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 5mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Perindopril 4mg TAB Prexum Vectoryl Cipla-perindopril Accepted treatment

Perindopril 8mg TAB Vectoryl Cipla-perindopril Accepted treatment

Perindopril 10mg TAB Prexum Coversyl Accepted treatment

Ramipril 1.25mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 10mg CAP Austell-ramipril Ran-ramipril Rampil Motivation required

Ramipril 2.5mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 5mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Trandolapril 0.5mg CAP Mavik Accepted treatment

Trandolapril 2mg CAP Mavik Accepted treatment

Captopril and diuretic 50mg/25mg TAB Captoretic Zapto-Co Capozide Accepted treatment

Enalapril and diuretic 12.5mg TAB Enap Co Pharmapress Co Accepted treatment

Lisinopril and diuretic 10mg/12.5mg TAB Lisoretic Lisozide Hexal-lisinopril Co Accepted treatment

Lisinopril and diuretic 20mg/12.5mg TAB Lisoretic Zestozide Hexal-lisinopril Co Accepted treatment

Perindopril and indapamide 4mg/1.5mg TAB Prexum Plus Vectoryl Plus Accepted treatment

Angiotensin receptor blockers and combinations

Losartan 50mg TAB Lepitrin Cipla-losartan Los-arb Accepted treatment

Losartan 100mg TAB Zartan Cipla-losartan Accepted treatment

Valsartan 160mg TAB Tareg Motivation required

Page 10: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

10

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Valsartan 320mg TAB Diovan Motivation required

Valsartan 40mg TAB Diovan Motivation required

Valsartan 80mg TAB Tareg Motivation required

Losartan and diuretic 100mg/25mg TAB Fortzaar Accepted treatment

Losartan and diuretic 50mg/12.5mg TAB Cozaar Comp Accepted treatment

Valsartan and diuretic 160mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretic 160mg/25mg TAB Co-diovan Plus Motivation required

Valsartan and diuretic 320mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretic 320mg/50mg TAB Co-diovan Motivation required

Valsartan and diuretic 80mg/12.5mg TAB Co-tareg Motivation required

Calcium channel blockers

Amlodipine 10mg TAB Almadin Ciplavasc Amlate Accepted treatment

Amlodipine 5mg TAB Almadin Ciplavasc Amlate Accepted treatment

Diltiazem 240mg SRT Zildem SR Accepted treatment

Diltiazem 180mg SRT Zildem SR Accepted treatment

Diltiazem 60mg TAB Zildem Accepted treatment

Diltiazem 90mg TAB Zildem Accepted treatment

Felodipine 10mg SRT Felodipine-hexal Accepted treatment

Felodipine 5mg SRT Felodipine-hexal Accepted treatment

Nifedipine 20mg SRT Nifedalat SR Cipalat Retard Accepted treatment

Nifedipine 30mg SRT Adco-Vascard SR Fedaloc Accepted treatment

Nifedipine 60mg SRT Fedaloc Macorel Motivation required

Verapamil 240mg SRT Verahexal Calcicard Ravamil Accepted treatment

Beta blockers and combinations

Atenolol 100mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 25mg TAB Tenopress Accepted treatment

Atenolol 50mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Bisoprolol 10mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Bisoprolol 2.5mg TAB Cardicor Accepted treatment

Bisoprolol 5mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Propranolol 10mg TAB Indoblok Prodorol Purbloka Accepted treatment

Propranolol 40mg TAB Indoblok Prodorol Purbloka Accepted treatment

Atenolol and other diuretics 100mg/25mg TAB Sandoz Co-tenidone Tenchlor Adco-loten Accepted treatment

Atenolol and other diuretics 50mg/12.5mg TAB Sandoz Co-tenidone Tenchlor HS Accepted treatment

Page 11: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

11

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Erythropoietin and supplements

Alfacalcidol 0.25mg CAP One alpha Special investigations

Alfacalcidol 1mg CAP One alpha Special investigations

Calcium carbonate TAB Titralac Special investigations

Erythropoietin INJ Repotin Recormon Eprex Special investigations

Iron in other combinations INJ Venofer Cosmofer Special investigations

Iron supplementation subject to Qualsa Medicine Reimbursement Policy.

Coronary artery disease

Aspirin

Acetylsalicylic acid 100mg TAB Bayer aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf aspirin Be-tabs aspirin Aspirin (Resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Calcium channel blockers

Amlodipine 10mg TAB Almadin Ciplavasc Amlate Accepted treatment

Amlodipine 5mg TAB Almadin Ciplavasc Amlate Accepted treatment

Diltiazem 240mg SRT Zildem SR Accepted treatment

Diltiazem 180mg SRT Zildem SR Accepted treatment

Diltiazem 60mg TAB Zildem Accepted treatment

Diltiazem 90mg TAB Zildem Accepted treatment

Felodipine 10mg SRT Felodipine-hexal Accepted treatment

Felodipine 5mg SRT Felodipine-hexal Accepted treatment

Nifedipine 20mg SRT Nifedalat SR Cipalat Retard Accepted treatment

Nifedipine 30mg SRT Adco-Vascard SR Fedaloc Accepted treatment

Nifedipine 60mg SRT Fedaloc Macorel Motivation required

Verapamil 240mg SRT Verahexal Calcicard Ravamil Accepted treatment

Verapamil 40mg TAB Vasomil Accepted treatment

Verapamil 80mg TAB Vasomil Accepted treatment

Beta blockers

Atenolol 100mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 25mg TAB Tenopress Accepted treatment

Atenolol 50mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Page 12: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

12

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Bisoprolol 10mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Bisoprolol 2.5mg TAB Cardicor Accepted treatment

Bisoprolol 5mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Propranolol 10mg TAB Indoblok Prodorol Purbloka Accepted treatment

Propranolol 40mg TAB Indoblok Prodorol Purbloka Accepted treatment

Alpha/beta blockers

Carvedilol 12.5mg TAB Carloc Carvetrend Vediblok Accepted treatment

Carvedilol 25mg TAB Carloc Carvetrend Vediblok Accepted treatment

Carvedilol 6.25mg TAB Carloc Carvetrend Vediblok Accepted treatment

Organic nitrates

Glyceryl trinitrate 0.5mg TAB Angised Accepted treatment

Isosorbide dinitrate 10mg TAB Sandoz Isosorbide dinitrate Accepted treatment

Isosorbide dinitrate 30mg TAB Sandoz Isosorbide Accepted treatment

Isosorbide dinitrate 40mg TAB Isordil Tembid Accepted treatment

Isosorbide dinitrate 5mg TAB Sandoz Isosorbide dinitrate Accepted treatment

Isosorbide mononitrate 20mg TAB Elantan Accepted treatment

Isosorbide mononitrate 50mg SRC Elantan LA Accepted treatment

Isosorbide mononitrate 60mg SRT Monicor Imdur Accepted treatment

Crohn's disease

Corticosteroids, topical

Budesonide ENE Entocord Motivation required

Corticosteroids, oral

Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment

Prednisone 5mg TAB Be-tabs prednisone Panafcort Trolic Accepted treatment

5-ASA agents

Mesalazine 2g/50ml ENE Asacol Motivation required

Mesalazine 400mg TAB Asacol Motivation required

Mesalazine 800mg TAB Asacol Motivation required

Mesalazine 500mg TAB/SUP Asacol Pentasa Motivation required

Olsalazine 250mg CAP Dipentum Motivation required

Sulphasalazine 500mg TAB Salazopyrin Accepted treatment

Immunosuppressants

Azathioprine 50mg TAB Zaprine Azathioprine 50 PCH Azapress Accepted treatment

Methotrexate 2.5mg TAB Methotrexate Emthexate Accepted treatment

Page 13: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

13

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Diabetes insipidus

Vasopressin analogues

Desmopressin 0.1mg TAB DDAVP Motivation required

Desmopressin 0.1mg/ml NAS/NOD DDAVP nasal spray 5ml DDAVP 2.5ml Motivation required

Desmopressin 0.2mg TAB DDAVP Motivation required

Diabetes mellitus type I

Insulin

Insulin (human) INJ Humulin Actraphane Protaphane Accepted treatment

Insulin aspart INJ Novorapid Novomix Accepted treatment

Insulin glulisine INJ Apidra Accepted treatment

Insulin lispro INJ Humalog Humalog Mix Accepted treatment

Insulin glargine (analogue) INJ Lantus Accepted treatment

Insulin determir (analogue) INJ Levemir Accepted treatment

Diabetes mellitus type II

Suphonylureas

Glibenclamide 5mg TAB Sandoz Glibenclamide Diacare Glycomin Accepted treatment

Gliclazide 40mg TAB Austell-gliclazide Accepted treatment

Gliclazide 80mg TAB Austell-gliclazide Mylan-gliclazide Sandoz Gliclazide Accepted treatment

Insulin

Insulin (human) INJ Humulin Actraphane Protaphane Accepted treatment

Insulin aspart INJ Novorapid Novomix Accepted treatment

Insulin glulisine INJ Apidra Accepted treatment

Insulin lispro INJ Humalog Humalog Mix Accepted treatment

Insulin glargine (analogue) INJ Lantus Accepted treatment

Insulin determir (analogue) INJ Levemir Accepted treatment

Biguanides

Metformin 1000mg TAB Glucophage Bigsens Metored Accepted treatment

Metformin 500mg TAB Austell-metformin Bigsens Forminal Accepted treatment

Metformin 850mg TAB Austell-metformin Bigsens Forminal Accepted treatment

Metformin 500mg XR TAB Glucophage XR Accepted treatment

Thiazolidinediones

Pioglitazone 15mg TAB Cipla-pioglitazone Motivation required

Pioglitazone 30mg TAB Cipla-pioglitazone Motivation required

Page 14: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

14

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Dysrhythmias

Aspirin

Acetylsalicylic acid 100mg TAB Bayer aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf aspirin Be-tabs aspirin Aspirin (Resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Anticoagulants

Warfarin 1mg TAB Cipla-warfarin Accepted treatment

Warfarin 3mg TAB Cipla-warfarin Accepted treatment

Warfarin 5mg TAB Cipla-warfarin Lennon warfarin Accepted treatment

Calcium channel blockers

Diltiazem 240mg SRT Zildem SR Accepted treatment

Diltiazem 180mg SRT Zildem SR Accepted treatment

Verapamil 240mg SRT Verahexal Calcicard Ravamil Accepted treatment

Verapamil 40mg TAB Vasomil Accepted treatment

Verapamil 80mg TAB Vasomil Accepted treatment

Beta blockers

Atenolol 100mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 25mg TAB Tenopress Accepted treatment

Atenolol 50mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Bisoprolol 10mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Bisoprolol 2.5mg TAB Cardicor Accepted treatment

Bisoprolol 5mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Propranolol 10mg TAB Indoblok Prodorol Purbloka Accepted treatment

Propranolol 40mg TAB Indoblok Prodorol Purbloka Accepted treatment

Sotalol 160mg TAB Sotahexal Motivation required

Sotalol 80mg TAB Sotahexal Motivation required

Cardiac glycosides

Digoxin 0.05mg/ml SYR Lanoxin Paed Accepted treatment

Digoxin 0.0625mg TAB Lanoxin Accepted treatment

Digoxin 0.25mg TAB Lanoxin Purgoxin Accepted treatment

Antiarrhythmics

Amiodarone 100mg TAB Arycor Hexarone Accepted treatment

Page 15: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

15

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Amiodarone 200mg TAB Arycor Hexarone Bio-Amiodarone Accepted treatment

Disopyramide 100mg CAP Rythmodan Motivation required

Disopyramide 250mg TAB Rythmodan Motivation required

Flecainide 100mg TAB Tambocor Motivation required

Propafenone 150mg TAB Rhythmol Motivation required

Propafenone 300mg TAB Rhythmol Motivation required

Quinidine sulphate 200mg TAB Quinidine Motivation required

Epilepsy

Anticonvulsants

Carbamazepine 100mg/5ml SUS Tegretol S Accepted treatment

Carbamazepine 200mg TAB/SRT Sandoz Carbamazepine CR Degranol CPL-carbamazepine Accepted treatment

Carbamazepine 400mg SRT Sandoz Carbamazepine CR Accepted treatment

Ethosuxamide 250mg/5ml SYR Zarontin Accepted treatment

Gabapentin 100mg CAP Neurexal Epleptin Ran-gabapentin Motivation required

Gabapentin 300mg CAP Neurexal Epleptin Ran-gabapentin Motivation required

Gabapentin 400mg CAP Neurexal Epleptin Ran-gabapentin Motivation required

Gabapentin 600mg TAB Neurontin Motivation required

Gabapentin 800mg TAB Neurontin Motivation required

Lamotrigine 100mg TAB Aspen-lamotrigine Lamitor Dyna-Lamotrigine Accepted treatment

Lamotrigine 200mg TAB Lamidus Austell-lamotrigine Dyna-Lamotrigine Accepted treatment

Lamotrigine 25mg TAB Aspen-lamotrigine Lamitor Dyna-Lamotrigine Accepted treatment

Lamotrigine 50mg TAB Aspen-lamotrigine Lamitor Dyna-Lamotrigine Accepted treatment

Phenobarbital 30mg TAB Sedabard Lethyl Accepted treatment

Phenobarbital SYR Adco-phenobarb vital Accepted treatment

Phenytoin 100mg TAB/CAP Phenytoin sod Epanutin Accepted treatment

Phenytoin 125mg/5ml SUS Epanutin Accepted treatment

Topiramate 15mg CAP Topamax cs Motivation required

Topiramate 100mg TAB Toplep Adco-topiramate Sandoz-topiramate Motivation required

Topiramate 200mg TAB Toplep Adco-topiramate Sandoz-topiramate Motivation required

Topiramate 25mg TAB Toplep Adco-topiramate Sandoz-topiramate Motivation required

Topiramate 50mg TAB Toplep Adco-topiramate Sandoz-topiramate Motivation required

Valproic acid 100mg TAB Epilim Accepted treatment

Valproic acid 150mg CAP/SRT Convulex Epilim Accepted treatment

Valproic acid 200mg SRT Epilim Accepted treatment

Page 16: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

16

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Valproic acid 200mg/5ml SYR Epilim Accepted treatment

Valproic acid 300mg CAP Convulex Accepted treatment

Valproic acid 500mg CAP/SRT Convulex Epilim Accepted treatment

Valproic acid 50mg/ml SYR Convulex Accepted treatment

Benzodiazepine derivatives

Clonazepam 0.5mg TAB Rivotril Motivation required

Clonazepam 2.5mg DRP Rivotril Motivation required

Clonazepam 2mg TAB Rivotril Motivation required

Glaucoma

Beta blockers

Betoxalol 0.25% OPD Betoptic S 5ml Accepted treatment

Betoxalol 5mg/ml OPD Betoptic 5ml Accepted treatment

Carteolol 2% OPD Teoptic 5ml Accepted treatment

Levobunolol 5% OPD Betagan 7.5ml Accepted treatment

Metipranolol 3% OPD Beta-opthiole 5ml Accepted treatment

Metipranolol 6% OPD Beta-opthiole 5ml Accepted treatment

Timolol 1mg/g OPD Nyogel Accepted treatment

Timolol 2.5mg/ml OPD Timoptol Accepted treatment

Timolol 5mg/ml OPD Glaucosan Timoptol Accepted treatment

Parasympathomimetics

Pilocarpine 10mg/ml OPD Isopto-carpine Accepted treatment

Pilocarpine 20mg/ml OPD Isopto-carpine Accepted treatment

Pilocarpine 40mg/ml OPD Isopto-carpine Accepted treatment

Sympathomimetics

Brimonidine OPD Alphagan Purite Motivation required

Dipivefrine 1% OPD Propine Motivation required

Carbonic anhydrase inhibitors

Acetazolamide 250mg TAB Azomid Motivation required

Brinzolamide 1% OPD Azoptic 5ml eye suspension Motivation required

Dorzolamide 2% OPD Trusopt Motivation required

Prostaglandin analogues

Bimatoprost 0.3mg/3ml OPD Lumigan Accepted treatment

Latanoprost OPD Xalatan 2.5ml Accepted treatment

Travoprost 4% OPD Travatan Accepted treatment

Page 17: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

17

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Beta blockers, combinations

Timolol and dordolamide OPD Cosopt Motivation required

Timolol and latanoprost OPD Xalacom Motivation required

Timolol and travoprost OPD DuoTrav Motivation required

Haemophilia

Analgesics and antipyretics

Paracetamol 120mg/5ml SYR Feverpain Napamol Painblok Accepted treatment

Paracetamol 500mg TAB Napamol Gencetamol Antalgic Accepted treatment

Antifibrinolytics

Tranexamic acid 500mg TAB Cyklokapron Special investigations

Hyperlipidaemia

Aspirin

Acetylsalicylic acid 100mg TAB Bayer aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf aspirin Be-tabs aspirin Aspirin (Resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Fibrates

Bezafibrate 200mg TAB Bezalip Special investigations

Bezafibrate 400mg TAB Sandoz bezafibrate Bezachole SR Dyna-Bezafibrate SR Special investigations

Statins

Simvastatin 10mg TAB Arrow-simvastatin Zocor Michol Special investigations

Simvastatin 20mg TAB Arrow-simvastatin Zocor Michol Special investigations

Simvastatin 40mg TAB Arrow-simvastatin Zocor Michol Special investigations

Simvastatin 80mg TAB Zysim Cipla-simvastatin Michol Special investigations

Hypertension

Aspirin

Acetylsalicylic acid 100mg TAB Bayer aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf aspirin Be-tabs aspirin Aspirin (Resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Diuretics

Furosemide 10mg/ml SYR Lasix Oral Motivation required

Page 18: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

18

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Furosemide 40mg TAB Diuresix Mylan-furosemide Beuresis Accepted treatment

Hydrochlorothiazide 12.5mg TAB Ridaq Accepted treatment

Hydrochlorothiazide 25mg TAB Hexazide Ridaq Accepted treatment

Hydrochlorothiazide and amiloride

25mg/2.5mg TAB Amiloretic HS Accepted treatment

Hydrochlorothiazide and amiloride

50mg/5mg TAB Amiloretic Spec-Co-Amiloride Betaretic Accepted treatment

Indapamide 2.5mg TAB Cipla-Indapamide Daptril Mylan-indapamide Accepted treatment

Spironolactone 100mg TAB Spiractin Accepted treatment

Spironolactone 25mg TAB Spiractin Sandoz Spironolactone Accepted treatment

Triamterine and hydrochlorothiazide

50mg/25mg TAB Renezide Accepted treatment

Hydrochlorothiazide and potassium

50mg/300mg TAB Urirex K Accepted treatment

Potassium supplements

Potassium chloride 600mg TAB Plenish-K Sandoz K-600 Accepted treatment

ACE-inhibitors and combinations

Captopril 12.5mg TAB Captohexal Accepted treatment

Captopril 25mg TAB Captohexal Mylan-captopril Bio-captopril Accepted treatment

Captopril 50mg TAB Captohexal Mylan-captopril Zapto Accepted treatment

Enalapril 10mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 2.5mg TAB Renitec Accepted treatment

Enalapril 20mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 5mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Lisinopril 10mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 2.5mg TAB Austell-lisinopril Accepted treatment

Lisinopril 20mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 5mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Perindopril 4mg TAB Prexum Vectoryl Cipla-perindopril Accepted treatment

Perindopril 8mg TAB Vectoryl Cipla-perindopril Accepted treatment

Ramipril 1.25mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 10mg CAP Austell-ramipril Ran-ramipril Rampil Accepted treatment

Ramipril 2.5mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 5mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Trandolapril 0.5mg CAP Mavik Accepted treatment

Trandolapril 2mg CAP Mavik Accepted treatment

Captopril and diuretic 50mg/25mg TAB Captoretic Zapto-Co Capozide Accepted treatment

Page 19: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

19

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Enalapril and diuretic 12.5mg TAB Enap Co Pharmapress Co Accepted treatment

Lisinopril and diuretic 10mg/12.5mg TAB Lisoretic Lisozide Hexal-lisinopril Co Accepted treatment

Lisinopril and diuretic 20mg/12.5mg TAB Lisoretic Zestozide Hexal-lisinopril Co Accepted treatment

Perindopril and indapamide 4mg/1.5mg TAB Prexum Plus Vectoryl Plus Accepted treatment

Angiotensin receptor blockers and combinations

Losartan 50mg TAB Lepitrin Cipla-losartan Los-arb Accepted treatment

Losartan 100mg TAB Zartan Cipla-losartan Accepted treatment

Valsartan 160mg TAB Tareg Motivation required

Valsartan 320mg TAB Diovan Motivation required

Valsartan 40mg TAB Diovan Motivation required

Valsartan 80mg TAB Tareg Motivation required

Losartan and diuretic 100mg/25mg TAB Fortzaar Accepted treatment

Losartan and diuretic 50mg/12.5mg TAB Cozaar Comp Accepted treatment

Valsartan and diuretic 160mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretic 160mg/25mg TAB Co-diovan Plus Motivation required

Valsartan and diuretic 320mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretic 320mg/50mg TAB Co-diovan Motivation required

Valsartan and diuretic 80mg/12.5mg TAB Co-tareg Motivation required

Calcium channel blockers

Amlodipine 10mg TAB Almadin Ciplavasc Amlate Accepted treatment

Amlodipine 5mg TAB Almadin Ciplavasc Amlate Accepted treatment

Diltiazem 240mg SRT Zildem SR Accepted treatment

Diltiazem 180mg SRT Zildem SR Accepted treatment

Diltiazem 60mg TAB Zildem Accepted treatment

Diltiazem 90mg TAB Zildem Accepted treatment

Felodipine 10mg SRT Felodipine-hexal Accepted treatment

Felodipine 2.5mg SRT Plendil Accepted treatment

Felodipine 5mg SRT Felodipine-hexal Accepted treatment

Nifedipine 20mg SRT Nifedalat SR Cipalat Retard Accepted treatment

Nifedipine 30mg SRT Adco-Vascard SR Fedaloc Accepted treatment

Nifedipine 60mg SRT Fedaloc Macorel Motivation required

Verapamil 240mg SRT Verahexal Calcicard Ravamil Accepted treatment

Beta blockers and combinations

Atenolol 100mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Page 20: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

20

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Atenolol 25mg TAB Tenopress Accepted treatment

Atenolol 50mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Bisoprolol 10mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Bisoprolol 2.5mg TAB Cardicor Accepted treatment

Bisoprolol 5mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Propranolol 10mg TAB Indoblok Prodorol Purbloka Accepted treatment

Propranolol 40mg TAB Indoblok Prodorol Purbloka Accepted treatment

Atenolol and other diuretics 100mg/25mg TAB Sandoz Co-tenidone Tenchlor Adco-loten Accepted treatment

Atenolol and other diuretics 50mg/12.5mg TAB Sandoz Co-tenidone Tenchlor HS Accepted treatment

Alpha/beta blockers

Carvedilol 12.5mg TAB Carloc Carvetrend Vediblok Accepted treatment

Carvedilol 25mg TAB Carloc Carvetrend Vediblok Accepted treatment

Carvedilol 6.25mg TAB Carloc Carvetrend Vediblok Accepted treatment

Alpha blockers

Doxazosin 1mg TAB Adco-doxazosin Cardugen Accepted treatment

Doxazosin 2mg TAB Adco-doxazosin Accepted treatment

Doxazosin 4mg TAB Adco-doxazosin Cardugen Accepted treatment

Doxazosin (Extended release)

4mg TAB Cardura XL Motivation required

Doxazosin (Extended release)

8mg TAB Cardura XL Motivation required

Prazosin 1mg TAB Pratsiol Accepted treatment

Prazosin 2mg TAB Pratsiol Accepted treatment

Prazosin 5mg TAB Pratsiol Accepted treatment

Vasodilators

Hydralazine 10mg TAB Hyperphen Accepted treatment

Hydralazine 25mg TAB Sandoz Hydralazine Accepted treatment

Hydralazine 50mg TAB Hyperphen Sandoz Hydralazine Accepted treatment

Minoxidil 10mg TAB Loniten Motivation required

Minoxidil 5mg TAB Loniten Motivation required

Antiadrenegic agents, centrally acting

Methyldopa 250mg TAB Hypotone Sandoz Methyldopa Mylan-methyldopa Accepted treatment

Methyldopa 500mg TAB Hypotone Accepted treatment

Reserpine 0.25mg TAB Reserpine Accepted treatment

Reserpine and diuretics TAB Brinerdin Motivation required

Page 21: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

21

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Hypothyroidism

Thyroid hormones

Levothyroxine 100mcg TAB Eltroxin Euthyrox Accepted treatment

Levothyroxine 50mcg TAB Eltroxin Euthyrox Accepted treatment

Levothyroxine 25mcg TAB Euthyrox Accepted treatment

Liothyronine 20mcg TAB Tertroxin Accepted treatment

Thyroxine and liothyronine 90mcg/10mcg TAB Diotroxin Accepted treatment

Multiple sclerosis

Heterocyclic antidepressants

Amitriptyline 10mg TAB Trepiline Accepted treatment

Amitriptyline 25mg TAB Trepiline Sandoz-amitriptyline Accepted treatment

Imipramine 10mg TAB Ethipramine Accepted treatment

Imipramine 25mg TAB Ethipramine Accepted treatment

Anticonvulsants

Carbamazepine 200mg TAB/SRT Sandoz Carbamazepine CR Degranol CPL-carbamazepine Accepted treatment

Carbamazepine 400mg SRT Sandoz Carbamazepine CR Accepted treatment

Immunosuppressants

Azathioprine 50mg TAB Zaprine Azathioprine 50 PCH Azapress Accepted treatment

Cyclophosphamide 50mg TAB Endoxan Motivation required

Methotrexate 2.5mg TAB Methotrexate Emthexate Accepted treatment

Muscle relaxants

Baclofen 10mg TAB Bio-baclofen Accepted treatment

Baclofen 25mg TAB Lioresal Motivation required

Orphenadrine 50mg TAB Disipal Accepted Treatment

Orphenadrine 100mg TAB Norflex Accepted treatment

Corticosteroids, oral

Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment

Prednisone 5mg TAB Be-tabs prednisone Panafcort Trolic Accepted treatment

Anticholinergics, oral

Oxybutynin 5mg TAB Lenditro Mylan-oxybutynin Urihexal Accepted treatment

Parkinson's disease

Dopa and dopa derivatives

Carbidopa and levodopa 25mg/100mg TAB Carbilev Accepted treatment

Carbidopa and levodopa 25mg/250mg TAB Carbilev Accepted treatment

Page 22: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

22

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Carbidopa and levodopa 50mg/200mg SRT Sinemet CR Accepted treatment

Levodopa and benserazide 100mg/25mg CAP Madopar HBS Accepted treatment

Levodopa and benserazide 200mg/50mg TAB Madopar Accepted treatment

Anticholinergics, oral

Biperiden 2mg TAB Akineton Accepted treatment

Orphenadrine 100mg TAB Norflex Accepted treatment

Orphenadrine 50mg TAB Disipal Accepted treatment

Adamantine derivatives

Amantadine 100mg CAP Symadin Accepted treatment

Dopamine agonists

Bromocriptine 2.5mg TAB Aspen-Bromocriptine Motivation required

Pramipexole 0.125mg TAB Pexola Motivation required

Pramipexole 0.25mg TAB Pexola Motivation required

Pramipexole 1mg TAB Pexola Motivation required

Ropinirole 0.25mg TAB Requip Motivation required

Ropinirole 0.5mg TAB Requip Motivation required

Ropinirole 1mg TAB Requip Motivation required

Ropinirole 2mg TAB Requip Requip XL Motivation required

Ropinirole 4mg TAB Requip XL Motivation required

Ropinirole 5mg TAB Requip Motivation required

Ropinirole 8mg TAB Requip XL Motivation required

Monoamine oxidase type B inhibitors

Selegiline 5mg TAB Parkilyne Accepted treatment

Rheumatoid arthritis

Immunosuppressants

Azathioprine 50mg TAB Zaprine Azathioprine 50 PCH Azapress Accepted treatment

Leflunomide 10mg TAB Arava Motivation required

Leflunomide 20mg TAB Arava Motivation required

Methotrexate 2.5mg TAB Methotrexate Emthexate Accepted treatment

Sulphasalazine 500mg TAB Salazopyrin Accepted treatment

Other

Chloroquine 150mg TAB Daramal Accepted treatment

Chloroquine 200mg TAB/CAP Nivaquine Plasmoquine Accepted treatment

Page 23: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

23

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Corticosteroids, oral

Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment

Prednisone 5mg TAB Be-tabs prednisone Panafcort Trolic Accepted treatment

Non-steroidal anti-inflammatory drugs

Diclofenac 100mg SRT/CAP Fortfen SR Sandoz Diclofenac sodium

SR Difen SR Accepted treatment

Diclofenac 25mg TAB Mylan-diclofenac sodium Diclohexal A-lennon diclofenac Accepted treatment

Diclofenac 50mg TAB Mylan-diclofenac sodium Diclohexal A-lennon diclofenac Accepted treatment

Diclofenac 75mg CAP/TAB Panamor SR Veltex CR Accepted treatment

Ibuprofen 100mg/5ml SUS Ibumax Ibugesic Advil paediatric suspension Accepted treatment

Ibuprofen 200mg TAB Ranfen Ibunate Betaprofen Accepted treatment

Ibuprofen 400mg TAB Ranfen Adco-ibuprofen Betaprofen 400 FC Accepted treatment

Ibuprofen 600mg TAB Sandoz Ibuprofen Accepted treatment

Indomethacin 100mg SUP Arthrexin Motivation required

Indomethacin 25mg CAP Betacin Gulf-indomethacin Adco-indomethacin Accepted treatment

Indomethacin 50mg CAP Arthrexin Accepted treatment

Ketoprofen 200mg SRT Ketoflam Accepted treatment

Meloxicam 15mg TAB Zydus-meloxicam Flexocam Loxiflam Accepted treatment

Meloxicam 7.5mg TAB Zydus-meloxicam Flexocam Loxiflam Accepted treatment

Naproxen 250mg TAB/ECT Mylan-naproxen Napflam Naprel Accepted treatment

Naproxen 500mg TAB Napflam Accepted treatment

Naproxen 500mg SUP Nafasol Motivation required

Piroxicam 10mg CAP Adco-piroxicam Accepted treatment

Piroxicam 20mg CAP/DSP Xycam Roxifen Pyrocaps Accepted treatment

Analgesics and antipyretics

Paracetamol 120mg/5ml SYR Feverpain Napamol Painblok Accepted treatment

Paracetamol 500mg TAB Napamol Gencetamol Antalgic Accepted treatment

Paracetamol combinations excl. psycholeptics

500mg/10mg TAB Napacod Accepted treatment

Schizophrenia

Heterocyclic antidepressants

Amitriptyline 25mg TAB Trepiline Sandoz-amitriptyline Accepted treatment

Dothiepin (dosulepin) 25mg CAP Thaden Sandoz-dothiepin Accepted treatment

Dothiepin (dosulepin) 75mg TAB Thaden Sandoz-dothiepin Accepted treatment

Imipramine 25mg TAB Ethipramine Accepted treatment

Page 24: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

24

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Maprotiline 25mg TAB Ludiomil Motivation required

Maprotiline 75mg TAB Ludiomil Motivation required

Selective serotonin receptor inhibitors

Citalopram 10mg TAB Austell-citalopram Accepted treatment

Citalopram 20mg TAB Austell-citalopram Citalopram-Winthrop Sandoz-citalopram Accepted treatment

Citalopram 40mg TAB Austell-citalopram Citalopram-Winthrop Depramil Accepted treatment

Fluoxetine 20mg CAP/TAB A-lennon fluoxetine Zydus-fluoxetine Ranflocs Accepted treatment

Fluoxetine 40mg DSP Prohexal T Motivation required

Other

Sulpiride 200mg TAB Bio-sulpiride Motivation required

Sulpiride 25mg SYR Eglonyl Motivation required

Sulpiride 50mg CAP Espiride Sandoz Sulpiride Motivation required

Mood stabilisers

Lithium 250mg TAB Camcolit Accepted treatment

Lithium 400mg TAB Camcolit Accepted treatment

Lithium 450mg TAB Quilonum Retard Accepted treatment

Antipsychotics

Chlorpromazine 100mg TAB Largactil Accepted treatment

Chlorpromazine 25mg TAB Largactil Accepted treatment

Chlorpromazine 50mg TAB Largactil Accepted treatment

Clozapine 100mg TAB Cloment Accepted treatment

Clozapine 25mg TAB Cloment Accepted treatment

Haloperidol 0.5mg CAP Serenace Accepted treatment

Haloperidol 1.5mg TAB Serenace Sandoz Haloperidol Accepted treatment

Haloperidol 10mg TAB Serenace Accepted treatment

Haloperidol 5mg TAB Serenace Sandoz Haloperidol Accepted treatment

Risperidone 0.5mg TAB DRL-Risperidone Risperidone-Hexal Mylan-Risperidone Motivation required

Risperidone 1mg TAB DRL-Risperidone Risperidone-Hexal Mylan-Risperidone Motivation required

Risperidone 2mg TAB DRL-Risperidone Risperidone-Hexal Mylan-Risperidone Motivation required

Risperidone 3mg TAB DRL-Risperidone Risperidone-Hexal Perizal Motivation required

Risperidone 4mg TAB Aspen Risperidone Risponz Motivation required

Trifluoperazine 1mg TAB Stelazine Accepted treatment

Trifluoperazine 5mg TAB Stelazine Accepted treatment

Zuclopenthixole 10mg TAB Clopixol Motivation required

Page 25: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

25

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Zuclopenthixole 2mg TAB Clopixol Motivation required

Systemic lupus erythematosus

Immunosuppressants

Methotrexate 2.5mg TAB Methotrexate Emthexate Accepted treatment

Other

Chloroquine 150mg TAB Daramal Accepted treatment

Chloroquine 200mg TAB/CAP Nivaquine Plasmoquine Accepted treatment

Aspirin

Acetylsalicylic acid 100mg TAB Bayer aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf aspirin Be-tabs aspirin Aspirin (Resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Corticosteroids, oral

Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment

Prednisone 5mg TAB Be-tabs prednisone Panafcort Trolic Accepted treatment

Non-steroidal anti-inflammatory drugs

Diclofenac 100mg SRT/CAP Fortfen SR Sandoz Diclofenac sodium

SR Difen SR Accepted treatment

Diclofenac 25mg TAB Mylan-diclofenac sodium Diclohexal A-lennon diclofenac Accepted treatment

Diclofenac 50mg TAB Mylan-diclofenac sodium Diclohexal A-lennon diclofenac Accepted treatment

Diclofenac 75mg CAP/TAB Panamor SR Veltex CR Accepted treatment

Ibuprofen 100mg/5ml SUS Ibumax Ibugesic Advil paediatric suspension Accepted treatment

Ibuprofen 200mg TAB Ranfen Ibunate Betaprofen Accepted treatment

Ibuprofen 400mg TAB Ranfen Adco-ibuprofen Betaprofen 400 FC Accepted treatment

Ibuprofen 600mg TAB Sandoz Ibuprofen Accepted treatment

Ibuprofen 800mg TAB Brufen Retard Motivation required

Indomethacin 100mg SUP Arthrexin Motivation required

Indomethacin 25mg CAP Betacin Gulf-indomethacin Adco-indomethacin Accepted treatment

Indomethacin 50mg CAP Arthrexin Accepted treatment

Ketoprofen 200mg SRT Ketoflam Accepted treatment

Meloxicam 15mg TAB Zydus-meloxicam Flexocam Loxiflam Accepted treatment

Meloxicam 7.5mg TAB Zydus-meloxicam Flexocam Loxiflam Accepted treatment

Naproxen 250mg TAB/ECT Mylan-naproxen Napflam Naprel Accepted treatment

Page 26: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

26

INGREDIENT STRENGTH DOSAGE FORM EXAMPLE 1 EXAMPLE 2 EXAMPLE 3 COMMENT

Naproxen 500mg TAB Napflam Accepted treatment

Naproxen 500mg SUP Nafasol Motivation required

Piroxicam 10mg CAP Adco-piroxicam Accepted treatment

Piroxicam 20mg CAP/DSP Xycam Roxifen Pyrocaps Accepted treatment

Corticosteroids, topical

Clobetasol 0.05% LOT Dermovate scalp Motivation required

Clobetasol 0.5mg CRM/UNG Dovate Xenovate Motivation required

Clobetasone CRM/UNG Eumovate Accepted treatment

Flucinolone 0.025mg/g CRM/UNG Cortoderm Accepted treatment

Betamethasone 0.10% CRM/UNG Persivate Repivate Vari-betamethasone Accepted treatment

Hydrocortisone 0.5mg UNG Dilucort Accepted treatment

Hydrocortisone 10mg/g CRM/UNG Vari-hydrocortisone Biocort (STX) Mylocort Accepted treatment

Hydrocortisone 5mg/g CRM/LOT Dilucort Link mezzoderm Accepted treatment

Ulcerative colitis

Corticosteroids, topical

Budesonide ENE Entocord Motivation required

Corticosteroids, oral

Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment

Prednisone 5mg TAB Be-tabs prednisone Panafcort Trolic Accepted treatment

5-ASA agents

Mesalazine 2g/50ml ENE Asacol Motivation required

Mesalazine 400mg TAB Asacol Motivation required

Mesalazine 800mg TAB Asacol Motivation required

Mesalazine 500mg TAB/SUP Asacol Pentasa Motivation required

Olsalazine 250mg CAP Dipentum Motivation required

Sulphasalazine 500mg TAB Salazopyrin Accepted treatment

Immunosuppressants

Azathioprine 50mg TAB Zaprine Azathioprine 50 PCH Azapress Accepted treatment

Page 27: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

27

DIAGNOSIS AND TREATMENT PAIRS (DTP) CONDITIONS

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Adrenocortical Hypersecretion

Diuretics

Spironolactone 100mg TAB Spiractin Accepted treatment

Spironolactone 25mg TAB Spiractin Sandoz Spironolactone Accepted treatment

Adrenocortical Insufficiency

Corticosteroids Oral

Hydrocortisone 10mg TAB Covocort Accepted treatment

Prednisone 5mg TAB Be-tabs prednisone Panafcort Accepted treatment

Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment

Fludrocortisone 0.1mg TAB Florinef acetate Motivation required

Anaemia

Iron supplementation, oral

Ferrous salts TAB / CAP Ferrous Sulphate Special investigations

Iron and folic acid TAB / CAP Pregmal Autrin Fero-folic Special investigations

Vitamin B

Folic acid 0.5mg TAB Folic acid Special investigations

Folic acid 5mg TAB / CAP Be-tabs folic acid Special investigations

Cyanocobalamin INJ Vitamin B12 Special investigations

Arrhythmias

Aspirin

Acetylsalicylic acid 100mg TAB Bayer aspirin cardio Disprin CV Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf aspirin Be-tabs aspirin Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment in children

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Antiarrythmics

Amiodarone 100mg TAB Arycor Hexarone Accepted treatment

Amiodarone 200mg TAB Arycor Hexarone Accepted treatment

Quinidine 200mg TAB Quinadine Motivation required

Page 28: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

28

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Disopyramide 100mg CAP Rythmodan Motivation required

Propafenone 150mg TAB Rhythmol Motivation required

Flecainide 100mg TAB Tambocor Motivation required

Betablockers

Atenolol 100mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 50mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 25mg TAB Tenopress Accepted treatment

Bisoprolol 10mg TAB Cardicor Bilocor Adco-Bisocor Accepted treatment

Bisoprolol 5mg TAB Cardicor Bilocor Adco-Bisocor Accepted treatment

Bisoprolol 2.5mg TAB Cardicor Accepted treatment

Propranolol 10mg TAB Indoblock Prodolol Purbloka Accepted treatment

Propronalol 40mg TAB Indoblock Prodolol Purbloka Accepted treatment

Sotalol 160mg TAB Sotahexal Motivation required

Sotalol 80mg TAB Sotahexal Motivation required

Cardiac Glycosides

Digoxin 0.05mg/ml SYR Lanoxin Paed Accepted treatment

Digoxin 0.0625mg TAB Lanoxin Accepted treatment

Digoxin 0.25mg TAB Lanoxin Purgoxin Accepted treatment

Calcium Channel Blockers

Diltiazem 180mg SRC Zildem SR Accepted treatment

Diltiazem 240mg SRC Zildem SR Accepted treatment

Diltiazem 90mg TAB Zildem Accepted treatment

Diltiazem 60mg TAB Zildem Accepted treatment

Verapamil 240mg SRT Verahexal Calcicard Ravamil Accepted treatment

Verapamil 80mg TAB Vasomil Accepted treatment

Verapamil 40mg TAB Vasomil Accepted treatment

Anticoagulants

Warfarin 5mg TAB Cipla-Warfarin Lennon warfarin Accepted treatment

Warfarin 3mg TAB Cipla-Warfarin Accepted treatment

Warfarin 1mg TAB Cipla-Warfarin Accepted treatment

Benign Prostatic Hypertrophy

Doxazosin 1mg TAB Adco-Doxazosin Cardugen Accepted treatment

Doxazosin 2mg TAB Adco-Doxazosin Accepted treatment

Page 29: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

29

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Doxazosin 4mg TAB Adco-Doxazosin Cardugen Accepted treatment

Doxazosin (Extended Release)

4mg TAB Carzin XL Cardura XL Motivation required

Doxazosin (Extended Release)

8mg TAB Cardura XL Motivation required

Prazosin 1mg TAB Pratsiol Accepted treatment

Prazosin 2mg TAB Pratsiol Accepted treatment

Prazosin 5mg TAB Pratsiol Accepted treatment

Tamsulosin 0.4mg SRC Uromax Tamsul Flomax sr Motivation required

Finasteride 5mg TAB Fincar Finpro Proscar Motivation required

Dutasteride 0.5mg CAP Avodart Motivation required

Chronic Renal Failure

Ace Inhibitor and Combinations

Captopril 12.5mg TAB Captohexal Accepted treatment

Captopril 25mg TAB Captohexal Mylan Captopril Bio-Captopril Accepted treatment

Captopril 50mg TAB Captohexal Mylan Captopril Zapto Accepted treatment

Captopril and diuretics 50mg/25mg TAB Captoretic Zapto Co Capozide Accepted treatment

Enalapril 2.5mg TAB Renitec Accepted treatment

Enalapril 5mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 10mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 20mg TAB Alapren Ciplatec Pharmaperss Accepted treatment

Enalaprin and diuretics 20mg/12.5mg TAB Enap Co Pharmapress Co Accepted treatment

Lisinopril 20mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 10mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 5mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 2.5mg TAB Austell-lisinopril Accepted treatment

Lisinopril and diuretics 10mg/12.5mg TAB Lisoretic Lisozide Hexal-lisinopril Co Accepted treatment

Lisinopril and diuretics 20mg/12.5mg TAB Lisoretic Zestozide Hexal-lisinopril Co Accepted treatment

Perindopril 4mg TAB Prexum Vectoryl Cipla-Perindopril Accepted treatment

Perindopril 8mg TAB Vectoryl Cipla-Perindopril Accepted treatment

Perindopril 10mg TAB Prexum Coversyl Accepted treatment

Perindopril and diuretics 4mg/1.25mg TAB Prexum Plus Vectoryl Plus Accepted treatment

Ramipril 1.25mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 2.5mg TAB/CAP Austell-ramipril Ran-ramipril Rampil Accepted treatment

Ramipril 5mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Page 30: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

30

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Ramipril 10mg TAB/CAP Austell-ramipril Ran-ramipril Rampil Accepted treatment

Trandolapril 0.5mg CAP Mavik Accepted treatment

Trandolapril 2mg CAP Mavik Accepted treatment

Angiotensin Receptor Blockers

Losartan 100mg TAB Zartan Cipla-Losartan Accepted treatment

Losartan 50mg TAB Lepitrin Cipla-Losartan Los-arb Accepted treatment

Losartan and diuretics 100mg/12.5mg TAB Fortzaar Accepted treatment

Losartan and diuretics 50mg/12.5mg TAB Cozaar Comp Accepted treatment

Valsartan 320mg TAB Diovan Motivation required

Valsartan 160mg TAB Tareg Motivation required

Valsartan 80mg TAB Tareg Motivation required

Valsartan 40mg TAB Diovan Motivation required

Valsartan and diuretics 320mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretics 320mg/50mg TAB Co-diovan Motivation required

Valsartan and diuretics 160mg/25mg TAB Co-diovan Plus Motivation required

Valsartan and diuretics 160mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretics 80mg/12.5mg TAB Co-tareg Motivation required

Beta Blockers and Combinations

Atenolol 100mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 50mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 25mg TAB Tenopress Accepted treatment

Atenolol and other diuretics 100mg/25mg TAB Sandoz Co-tenidone Tenchlor Adco-loten Accepted treatment

Atenolol and other diuretics 50mg/12.5mg TAB Sandoz Co-tenidone Tenchlor HS Accepted treatment

Atenolol and thiazides 100mg/25mg TAB Adco-loten Accepted treatment

Bisoprolol 10mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Bisoprolol 5mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Bisoprolol 2.5mg TAB Cardicor Accepted treatment

Calcium Channel Blockers

Amlodipine 10mg TAB Almadin Ciplavasc Amlate Accepted treatment

Amlodipine 5mg TAB Almadin Ciplavasc Amlate Accepted treatment

Diltiazem 240mg SRC Zildem SR Accepted treatment

Diltiazem 180mg SRC Zildem SR Accepted treatment

Diltiazem 90mg TAB Zildem Accepted treatment

Diltiazem 60mg TAB Zildem Accepted treatment

Page 31: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

31

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Felodipine 10mg SRT Felodipine-hexal Accepted treatment

Felodipine 5mg SRT Felodipine-hexal Accepted treatment

Nifedipine 60mg TAB Fedaloc Macorel Accepted treatment

Nifedipine 30mg TAB Fedaloc Accepted treatment

Nifedipine 30mg SRT Adco-Vascard SR Fedaloc Accepted treatment

Nifedipine 20mg SRT Nifedalat SR Cipalat retard Accepted treatment

Diuretics

Hydrochlorothiazide 12.5mg TAB Ridaq Accepted treatment

Hydrochlorothiazide 25mg TAB Hexazide Ridaq Accepted treatment

Hydrochlorothiazide and potassium

50mg/300mg TAB Urirek-k Accepted treatment

Hydrochlorothiazide and potassium-sparing agents

25mg/2.5mg TAB Amiloretic hs Accepted treatment

Hydrochlorothiazide and potassium-sparing agents

50mg/25mg TAB Dyazide Accepted treatment

Hydrochlorothiazide and potassium-sparing agents

50mg/5mg TAB Amiloretic Accepted treatment

Indapamide 2.5mg TAB Cipla-Indapamide Daptril Mylan-indapamide Accepted treatment

Furosemide 40mg TAB/CAP Diuresix Mylan-Furosemide Accepted treatment

Furosemide 10mg/ml SYR Lasix Oral Motivation required in adults

Erythropoetin and Supplements

Alfacalcidol 0.25mcg TAB One Alpha Special investigation

Alfacalcidol 1mcg TAB One Alpha Special investigation

Ferrous fumarate TAB Pregamal Special investigation

Ferrous sulfate 30mg TAB Ferrous sulfate Special investigation

Ferrous sulfate 100mg TAB Ferrous sulfate Special investigation

Folic acid 0.5mg TAB

Folic acid Special investigation

Folic acid 5mg TAB Be-tabs folic acid Special investigation

Iron multivitamins and folic acid

100mg TAB Autrin Ferograd Special investigation

Iron multivitamins and folic acid

100mg TAB Foliferr Special investigation

Erythropoetin INJ Repotin Recormon Eprex Special investigation

Darbepoetin INJ Aranesp Special investigation

Iron in other combinations INJ Ferofolic Special investigation

Calcium carbonate 300mg CHU Caltrate 300 Special investigation

Calcium carbonate 500mg CHU Virtual care Calcium Special investigation

Page 32: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

32

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Calcium carbonate 500mg EFT Sandoz Calcium Forte Fizzical Special investigation

Calcium carbonate 500mg TAB Caltrate d Special investigation

Potassium Supplement

Potassium chloride 600mg TAB Plenish-K Accepted treatment

Hormone inhibitors

Cinacalcet 30mg TAB Senispar Motivation required

Cinacalcet 60mg TAB Senispar Motivation required

Complications of Hypertension

Calcium Channel Blockers

Amlodipine 10mg TAB Almadin Ciplavasc Amlate Accepted treatment

Amlodipine 5mg TAB Almadin Ciplavasc Amlate Accepted treatment

Diltiazem 240mg SRC Zildem SR Accepted treatment

Diltiazem 180mg SRC Zildem SR Accepted treatment

Diltiazem 90mg TAB Zildem Accepted treatment

Diltiazem 60mg TAB Zildem Accepted treatment

Verapamil 240mg SRT Verahexal Calcicard Ravamil Accepted treatment

Verapamil 80mg TAB Vasomil Accepted treatment

Verapamil 40mg TAB Vasomil Accepted treatment

Felodipine 10mg SRT Felodipine -hexal Accepted treatment

Nifedipine 60mg TAB Fedaloc Macorel Accepted treatment

Nifedipine 30mg TAB Fedaloc Accepted treatment

Nifedipine 30mg SRT Adco-Vascard SR Fedaloc Accepted treatment

Nifedipine 20mg SRT Nifedalat SR Cipalat Retard Accepted treatment

Cardiac Glycosides

Digoxin 0.05mg/ml SYR Lanoxin Paed Accepted treatment

Digoxin 0.0625mg TAB Lanoxin Accepted treatment

Digoxin 0.25mg TAB Lanoxin Accepted treatment

Diuretics

Hydrochlorothiazide and potassium-sparing agents

TAB Aldazide Accepted treatment

Furosemide 40mg TAB/CAP Diuresix Mylan-furosemide Beuresis Accepted treatment

Furosemide 10mg/ml SYR Lasix Oral Motivation required in adults

Indapamide 2.5mg TAB Cipla-Indapamide Daptril Mylan-indapamide Accepted treatment

Spironolactone 25mg TAB Spiractin Sandoz Spironolactone Accepted treatment

Page 33: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

33

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Spironolactone 100mg TAB Spiractin Accepted treatment

Anticoagulants

Dypiridamole 100mg TAB Plato Accepted treatment

Dypiridamole 200mg SRC Persantin retard Accepted treatment

Dypiridamole 200mg/25mg CAP Asasantin Retard Accepted treatment

Dypiridamole 25mg TAB Plato Accepted treatment

Warfarin 5mg TAB Cipla-Warfarin Lennon warfarin Accepted treatment

Warfarin 3mg TAB Cipla-Warfarin Accepted treatment

Warfarin 1mg TAB Cipla-Warfarin Accepted treatment

Vasodilators

Sildenafil 20mg TAB Revatio Motivation required

Cushing’s syndrome

Growth hormone release inhibitor

Ketoconazole 200mg TAB Ketazol Nizoral Motivation required

Octreotide 0.05mg INJ Sandostatin Motivation required

Octreotide 0.1mg INJ Sandostatin Motivation required

Octreotide 0.2mg INJ Sandostatin Motivation required

Octreotide 10mg INJ Sandostatin LAR pre-filled Motivation required

Octreotide 20mg INJ Sandostatin LAR pre-filled Motivation required

Delusional disorders

Heterocyclic antidepressants

Amitriptyline 25mg TAB Trepiline Sandoz-Amitryptyline Accepted treatment

Dothiepin (dosulepin) 25mg CAP Thaden Sandoz-Dothiepen Accepted treatment

Dothiepin (dosulepin) 75mg TAB Thaden Sandoz-Dothiepen Accepted treatment

Imipramine 25mg TAB Ethipramine Tofranil Accepted treatment

Maprotiline 25mg TAB Ludiomil Motivation required

Maprotiline 75mg TAB Ludiomil Motivation required

Selective serotonin receptor inhibitors

Citalopram 10mg TAB Austell-Citalopram Accepted treatment

Citalopram 20mg TAB Austell-Citalopram Citalopram-Winthrop Sandoz-Citalopram Accepted treatment

Citalopram 40mg TAB Austell-Citalopram Citalopram-Winthrop Depramil Accepted treatment

Fluoxetine 20mg CAP / TAB A-lennon fluoxetine Zydus Fluoxetine Ranflocs Accepted treatment

Fluoxetine 40mg DSP Prohexal T Motivation required

Page 34: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

34

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Other antidepressants

Sulpiride 200mg TAB Bio-Sulpiride Motivation required

Sulpiride 25mg SYR Eglonyl Motivation required

Sulpiride 50mg CAP Espiride Accepted treatment

Antipsychotics

Amisulpiride 200mg TAB Solian Motivation required

Amisulpiride 50mg TAB Solian Motivation required

Chlorpromazine 100mg TAB Largactil Accepted treatment

Chlorpromazine 25mg TAB Largactil Accepted treatment

Chlorpromazine 50mg TAB Largactil Accepted treatment

Clozapine 100mg TAB Cloment Accepted treatment

Clozapine 25mg TAB Cloment Accepted treatment

Haloperidol 0.5mg CAP Serenace Accepted treatment

Haloperidol 1.5mg TAB Serenace Sandoz Haloperidol Accepted treatment

Haloperidol 10mg TAB Serenace Accepted treatment

Haloperidol 5mg TAB Serenace Sandoz Haloperidol Accepted treatment

Risperidone 0.5mg TAB DRL-Risperidone Risperidone-Hexal Mylan-Risperidone Motivation required

Risperidone 1mg TAB DRL-Risperidone Risperidone-Hexal Mylan-Risperidone Motivation required

Risperidone 2mg TAB DRL-Risperidone Risperidone-Hexal Mylan-Risperidone Motivation required

Risperidone 3mg TAB DRL-Risperidone Risperidone-Hexal Perizal Motivation required

Risperidone 4mg TAB Aspen Risperidone Risponz Motivation required

Trifluoperazine 1mg TAB Stelazine Accepted treatment

Trifluoperazine 5mg TAB Stelazine Accepted treatment

Zuclopenthixole 10mg TAB Clopixal Motivation required

Zuclopenthixole 2mg TAB Clopixal Motivation required

Endometriosis

Hormonal preparations, oral

Cyproterone 2mg TAB Diva -35 Ginette Minerva Motivation required

Cyproterone 50mg TAB Cipla-Cyproterone Acetate Cyproplex Androcur Motivation required

Desogestrel and estrogen TAB Mercilon Marvelon Motivation required

Drospirenone and estrogen TAB Yasmin Yaz Motivation required

Gestodene and estrogen TAB Minulette Melodene Femodene ed Motivation required

Levonorgestrel and estrogen TAB Biphasil Triphasil Motivation required

Medroxyprogesterone 5mg TAB Hexal-PMA Provera Accepted treatment

Page 35: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

35

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Norethisterone 5mg TAB Primulot n Accepted treatment

Norethisterone and estrogen TAB Trinovum Motivation required

Norgestimate & oestrogen TAB Tricilest Motivation required

Antigonadotropins

Danazol 100mg CAP Danogen Ladazol Motivation required

Danazol 200mg CAP Danogen Ladazol Motivation required

Gonadotrophin Releasing Hormones and analogues

Goserelin 3.6mg INJ Zoladex Motivation required

Nafarelin 2 mg/mL NAS Synarel Motivation required

Leuprorelin 11.25mg INJ Lucrin Depot Motivation required

Hyperparathyroidism

Aminoquinolines

Chloroquine 150mg TAB Daramal Accepted treatment

Chloroquine 200mg TAB/CAP Nivaquine Plasmoquine Accepted treatment

Calcitonin

Calcitonin 200iu NAS Miacalcic nasal spray Motivation required

Calcitonin 100iu INJ Miacalcic Motivation required

Hormone inhibitors

Cinacalcet 30mg TAB Sensipar Motivation required

Cinacalcet 60mg TAB Sensipar Motivation required

Hyperthyroidism

Imidazole derivatives

Carbimazole 5mg TAB Neo-mercazole Motivation required

Beta blockers

Propranolol 10mg TAB Indoblok Prodorol Purbloka Accepted treatment

Propranolol 40mg TAB Indoblok Prodorol Purbloka Accepted treatment

Hypoparathyroidism

Calcium supplementation

Calcium TAB/EFT B-cal Accepted treatment

Calcium and vitamin D TAB B-cal d Caltrate d Accepted treatment

Idiopathic thrombocytopaenic purpura

Corticosteroids –Oral

Betamethasone 0.5mg TAB Betanoid Celestone Motivation required

Page 36: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

36

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment

Prednisone 5mg TAB Be-tabs prednisone Panafcort Accepted treatment

Alkylating agents

Cyclophosphamide 50mg TAB Endoxan Motivation required

Immunosuppressive agents

Azathioprine 50mg TAB Zaprine Azathioprine 50 PCH Azapress Accepted treatment

Methotrexate 2.5mg TAB Methotrexate Accepted treatment

Ischaemic Heart Disease

Aspirin

Acetylsalicylic acid 100mg TAB Bayer Aspirin Cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-Aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf Aspirin Be-Tabs Aspirin Aspirin (Resmed) Accepted treatment in children

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Anticoagulants

Warfarin 5mg TAB Cipla-Warfarin Lennon Warfarin Accepted treatment

Warfarin 3mg TAB Cipla-Warfarin Accepted treatment

Warfarin 1mg TAB Cipla-Warfarin Accepted treatment

Dypiridamole 100mg TAB Plato Accepted treatment

Dypiridamole 200mg SRC Persantin Accepted treatment

Dypiridamole 200mg/25mg CAP Asasantin Retard Accepted treatment

Dypiridamole 25mg TAB Plato Accepted treatment

Menopause

Hormone replacement therapy

Conjugated estrogen TAB Premarin Accepted treatment

Drospirenone and estrogen 1mg/2mg TAB Angeliq Accepted treatment

Dydrogesterone and estrogen

TAB Femoston conti Accepted treatment

Estradiol PAD/TAB/IMP Evorel Vagifem Accepted treatment

Estriol 2mg TAB Synapause e3 Accepted treatment

Medrogestone and estrogen TAB Premelle Accepted treatment

Medroxyprogesterone TAB Hexal PMA Provera Accepted treatment

Norethisterone and estrogen PAD/TAB Trinovum Accepted treatment

Norgestral and estrogen TAB Tricilest Accepted treatment

Page 37: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

37

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Alpha-2 agonists

Clonidine 0.025mg TAB Dixarit Menograine Accepted treatment

Mycobacterial Infections (Excluding TB)

Pulmonary Disease & Others

Rifampicin 600mg TAB Rimactane Special Investigations

Rifampicin 100mg/5ml SUS R-Cin rifampicin Special Investigations

Ethambutol 400mg TAB Sandoz Ethambutol Special Investigations

Clarithromycin 250mg TAB Clacee Special Investigations

Clarithromycin 500mg TAB Clacee Clarihexal Special Investigations

Clarithromycin 250mg/5ml SUS Clarihexal Ran-Clarithromycin Special Investigations

Clarithromycin 125mg/5ml SUS Clarihexal Ran-Clarithromycin Special Investigations

Tetracycline 250mg TABS/CAPS Be-oxytet Oxypan Special Investigations

Neonatal Cardiac Dysrhythmia

Antiarrhythmics

Amiodarone 100mg TAB Arycor Cordarone X Motivation required

Amiodarone 150mg/3ml INJ Cordarone X Motivation required

Quinidine 200mg TAB Quinidine Sulphate Motivation required

Disopyramide 100mg CAP Rhythmodan Motivation required

Propafenone 150mg TAB Rythmol Motivation required

Flecainide 100mg TAB Rythmol Motivation required

Beta blockers

Propranolol 10mg TAB Indoblok Prodorol Purbloka Accepted treatment

Sotalol 80mg TAB Sotahexal Motivation required

Atenolol 25mg TAB Tenopress Accepted treatment

Bisoprolol 2.5mg TAB Cardicor Accepted treatment

Cardiac Glycosides

Digoxin 0.05mg/ml SYR Lanoxin Paed Accepted treatment

Neonatal Cardiac Failure

Cardiac Glycosides

Digoxin 0.05mg/ml SYR Lanoxin Paed Accepted treatment

Diuretics

Furosemide 10mg/ml SYR Lasix Oral Accepted treatment

Page 38: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

38

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Nephritic Syndrome

Calcium Channel Blockers

Amlodipine 10mg TAB Almadin Ciplavasc Amlate Accepted treatment

Amlodipine 5mg TAB Almadin Ciplavasc Amlate Accepted treatment

Diltiazem 240mg SRC Zildem SR Accepted treatment

Diltiazem 180mg SRC Zildem SR Accepted treatment

Diltiazem 90mg TAB Zildem Accepted treatment

Diltiazem 60mg TAB Zildem Accepted treatment

Felodipine 10mg SRT Felodipine-hexal Accepted treatment

Felodipine 5mg SRT Felodipine-hexal Accepted treatment

Nifedipine 60mg SRT Fedaloc Motivation required

Nifedipine 30mg SRT Adco-Vascard SR Fedaloc Accepted treatment

Nifedipine 20mg SRT Nifedalat SR Cipalat Retard Accepted treatment

Diuretics

Hydrochlorothiazide 12.5mg TAB Ridaq Accepted treatment

Hydrochlorothiazide 25mg TAB Hexazide Ridaq Accepted treatment

Hydrochlorothiazide and potassium

50mg/300mg TAB Urirex K Accepted treatment

Hydrochlorothiazide and potassium-sparing agents

25mg/2.5mg TAB Amiloretic hs Accepted treatment

Hydrochlorothiazide and potassium-sparing agents

50mg/25mg TAB Dyazide Accepted treatment

Hydrochlorothiazide and potassium-sparing agents

50mg/5mg TAB Amiloretic Accepted treatment

Indapamide 2.5mg TAB Cipla-Indapamide Daptril Accepted treatment

Furosemide 40mg TAB/CAP Diuresix Mylan-Furosemide Beuresis Accepted treatment

Furosemide 10mg/ml SYR Lasix Oral Motivation required in adults

Beta Blocker and Combinations

Atenolol 100mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 50mg TAB Tenopress Sandoz Atenolol B-block Accepted treatment

Atenolol 25mg TAB Tenopress Accepted treatment

Atenolol and other diuretics 100mg/25mg TAB Sandoz Co-tenidone Accepted treatment

Atenolol and other diuretics 50mg/12.5mg TAB Sandoz Co-tenidone Accepted treatment

Atenolol and thiazides 100mg/25mg TAB Sandoz Co-tenidone Tenchlor Adco-loten Accepted treatment

Bisoprolol 10mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Bisoprolol 5mg TAB Cardicor Bilocor Adco-bisocor Accepted treatment

Page 39: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

39

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Bisoprolol 2.5mg TAB Cardicor Accepted treatment

Ace Inhibitor And Combinations

Captopril 12.5mg TAB Captohexal Accepted treatment

Captopril 25mg TAB Captohexal Mylan-captopril Bio-Captopril Accepted treatment

Captopril 50mg TAB Captohexal Mylan-captopril Zapto Accepted treatment

Captopril and diuretics 50mg/25mg TAB Captoretic Zapto-Co Capozide Accepted treatment

Enalapril 2.5mg TAB Renitec Accepted treatment

Enalapril 5mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 10mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalapril 20mg TAB Alapren Ciplatec Pharmapress Accepted treatment

Enalaprin and diuretics 20mg/12.5mg TAB Enap-Co Pharmapress co Accepted treatment

Lisinopril 20mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 10mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 5mg TAB Sinopren Simayla-lisinopril Zemax Accepted treatment

Lisinopril 2.5mg TAB Austell-lisinopril Accepted treatment

Lisinopril and diuretics 10mg/12.5mg TAB Lisoretic Lisozide Hexal-lisinopril Co Accepted treatment

Lisinopril and diuretics 20mg/12.5mg TAB Lisoretic Zestozide Hexal-lisinopril Co Accepted treatment

Perindopril 4mg TAB Prexum Vectoryl Cipla-Perindopril Accepted treatment

Perindopril 8mg TAB Vectoryl Cipla-perindopril Accepted treatment

Perindopril 10mg TAB Prexum Coversyl Accepted treatment

Perindopril and diuretics 4mg/1.25mg TAB Prexum plus Coversyl Plus Accepted treatment

Ramipril 1.25mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 2.5mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 5mg TAB/CAP Austell-ramipril Ramiwin Rampil Accepted treatment

Ramipril 10mg TAB/CAP Austell-ramipril Ran-ramipril Rampil Accepted treatment

Trandolapril 0.5mg CAP Mavik Accepted treatment

Trandolapril 2mg CAP Mavik Accepted treatment

Angiotensin receptor blockers and combinations

Losartan 100mg TAB Zartan Cipla-Losartan Accepted treatment

Losartan 50mg TAB Lepitrin Cipla-Losartan Los-Arb Accepted treatment

Losartan and diuretics 100mg/12.5mg TAB Fortzaar Accepted treatment

Losartan and diuretics 50mg/12.5mg TAB Cozaar-comp Accepted treatment

Valsartan 320mg TAB Diovan Motivation required

Page 40: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

40

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Valsartan 160mg TAB Tareg Motivation required

Valsartan 80mg TAB Tareg Motivation required

Valsartan 40mg TAB Diovan Motivation required

Valsartan and diuretics 320mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretics 320mg/25mg TAB Co-diovan Motivation required

Valsartan and diuretics 160mg/25mg TAB Co-diovan plus Motivation required

Valsartan and diuretics 160mg/12.5mg TAB Co-diovan Motivation required

Valsartan and diuretics 80mg/12.5mg TAB Co-tareg Motivation required

Potassium Supplements

Potassium chloride 600mg TAB Plenish-k Accepted treatment

Nephrogenic Diabetes Insipidus

Thiazide diuretic

Hydrochlorothiazide 25mg TAB Hexazide Ridaq Accepted treatment

Hydrochlorothiazide 12.5mg TAB Ridaq Accepted treatment

Neurological abnormalities of the newborn- Spasticity

Muscle relaxants

Baclofen 10mg TAB Bio-baclofen Teva-baclofen Lioresal Accepted treatment

Dantrolene 20mg/70ml INJ Dantrium Motivation required

Diabetes Mellitus – Complications (Neurological)

Tricyclic antidepressants

Amitryptiline 10mg TAB Trepiline Accepted treatment

Amitryptiline 25mg TAB Trepiline Sandoz Amitriptyline Accepted treatment

Anti-convulsants

Carbamazepine 200mg TAB Degranol CPL-carbamazepine Accepted treatment

Ovarian dysfunction Hormonal preparations, oral

Cyproterone 2mg TAB Diva -35 Ginette Minerva Motivation required

Cyproterone 50mg TAB Cipla-Cyproterone Acetate Cyproplex Androcur Motivation required

Desogestrel and estrogen TAB Mercilon Marvelon Motivation required

Drospirenone and estrogen TAB Yasmin Yaz Motivation required

Gestodene and estrogen TAB Minulette Melodene Femodene ed Motivation required

Levonorgestrel and estrogen TAB Biphasil Triphasil Motivation required

Norethisterone and estrogen TAB Trinovum Motivation required

Page 41: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

41

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Norgestimate & oestrogen TAB Tricilest Motivation required

Pemphigus and other disseminated bullous skin disease

Immuosuppressants

Azathioprine 50mg TAB Zaprine Azapress Azathioprine 50 PCH Accepted treatment

Methotrexate 2.5mg TAB Methotrexate Accepted treatment

Ciclosporin 25mg CAP Sandimmun neural soft gel Motivation required

Ciclosporin 100mg CAP Sandimmun neural soft gel Motivation required

Corticosteroids oral

Prednisone 5mg CAP Be-tabs prednisone Panafcort Trolic Accepted treatment

Prednisolone 5mg TAB Lenisolone Capsoid Accepted treatment

Alkylating agents

Cyclophosphamide 50mg TAB Endoxan Motivation required

Peptic Ulcer Disease

H2-receptor antagonists

Cimetidine 200mg TAB Bio-Cimetidine Cimlok Lenamet Accepted treatment

Cimetidine 400mg TAB Bio-Cimetidine Cimlok Lenamet Accepted treatment

Ranitidine 150mg TAB Ranihexal Ranit Histak Accepted treatment

Ranitidine 300mg TAB Ranihexal Ranit Histak Accepted treatment

Ranitidine 150mg/10ml SYR Zantac Motivation required

Proton Pump Inhibitors

Omeprazole 10mg CAP Omez Altosec DRL-omeprazole Accepted treatment

Omeprazole 20mg CAP Nozer Altosec Omez Accepted treatment

Omeprazole 40mg TAB/CAP Omez Losec mups DRL-omeprazole Accepted treatment

Pantoprazole 20mg TAB Topzole Pantoloc Controloc Motivation required

Pantoprazole 40mg TAB Topzole Pantoloc Controloc Motivation required

Esomeprazole 20mg TAB Nexiam Motivation required

Esomeprazole 40mg TAB Nexiam Motivation required

Lansoprazole 15mg TAB/CAP Lansoloc Lancap Aspen Lansoprazole Motivation required

Lansoprazole 30mg TAB/CAP Lansoloc Lancap Aspen Lansoprazole Motivation required

Rabeprazole 10mg TAB Pariet Motivation required

Rabeprazole 20mg TAB Pariet Motivation required

Page 42: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

42

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Peripheral vascular disease

Aspirin

Acetylsalicylic acid 100mg TAB Bayer aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-Aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf Aspirin Be-tabs aspirin Aspirin (Resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment in children

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Anticoagulants

Warfarin 1mg TAB Cipla-warfarin Accepted treatment

Warfarin 3mg TAB Cipla-warfarin Accepted treatment

Warfarin 5mg TAB Cipla-warfarin Lennon warfarin Accepted treatment

Pituitary hyperfunction

Dopamine Agonists

Bromocriptine 2.5mg TAB Aspen Bromocriptine Special investigations

Carbergoline 0.5mg TAB Dostinex Special investigations & motivation

Growth Hormone Release Inhibitors

Octreotide 0.05mg/ml INJ Sandostatin Special investigations

Pituitary hypofunction

Thyroid Hormones

Levothyroxine 100mcg TAB Eltroxin Euthyrox Accepted treatment

Levothyroxine 50mcg TAB Eltroxin Euthyrox Accepted treatment

Levothyroxine 25mcg TAB Euthyrox Accepted treatment

Liothyronine 20mcg TAB Tertroxin Accepted treatment

Thyroxine and liothyronine 90mcg/10mcg TAB Diotroxin Accepted treatment

Growth Hormone

Humatrope 6mg INJ Isopto homotropine Motivation required

Sex Hormones

Depo- Testosterone 100mg/ml INJ Depot testosterone Motivation required

Conjugated oestrogens 0.625 mg TAB Premarin Accepted treatment

Conjugated oestrogens 0.3mg TAB Premarin Accepted treatment

Glucocorticoids,oral

Hydrocortisone 10mg TAB Covocort Accepted treatment

Page 43: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

43

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Schizo-affective disorder

Heterocyclic antidepressants

Amitriptyline 25mg TAB Trepiline Accepted treatment

Dothiepin (dosulepin) 25mg CAP Thaden Sandoz -dothiepin Accepted treatment

Dothiepin (dosulepin) 75mg TAB Thaden Sandoz-dothiepin Accepted treatment

Imipramine 25mg TAB Ethipramine Accepted treatment

Maprotiline 25mg TAB Ludiomil Motivation required

Maprotiline 75mg TAB Ludiomil Motivation required

Selective serotonin receptor inhibitors

Citalopram 10mg TAB Austell-citalopram Accepted treatment

Citalopram 20mg TAB Austell-citalopram Citalopram-Winthrop Sandoz-citalopram Accepted treatment

Citalopram 40mg TAB Austell-citalopram Citalopram-Winthrop Depramil Accepted treatment

Fluoxetine 20mg CAP / TAB A-lennon fluoxetine Zydus-fluoxetine Ranflocs Accepted treatment

Fluoxetine 40mg DSP Prohexal T Motivation required

Other

Sulpiride 200mg TAB Bio-Sulpiride Motivation required

Sulpiride 25mg SYR Eglonyl Motivation required

Sulpiride 50mg CAP Espiride Sandoz Sulpiride Accepted treatment

Monoamine oxidase type A inhibitors

Moclobemide 150mg TAB Depnil Motivation required

Moclobemide 300mg TAB Depnil Motivation required

Mood stabilisers

Lithium 250mg TAB Camcolit Accepted treatment

Lithium 400mg TAB Camcolit Accepted treatment

Lithium 450mg TAB Quinolum Retard Accepted treatment

Antipsychotics

Amisulpiride 200mg TAB Solian Motivation required

Amisulpiride 50mg TAB Solian Motivation required

Chlorpromazine 100mg TAB Largactil Accepted treatment

Chlorpromazine 25mg TAB Largactil Accepted treatment

Chlorpromazine 50mg TAB Largactil Accepted treatment

Clozapine 100mg TAB Cloment Accepted treatment

Clozapine 25mg TAB Cloment Accepted treatment

Page 44: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

44

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Haloperidol 0.5mg CAP Serenace Accepted treatment

Haloperidol 1.5mg TAB Serenace Sandoz Haloperidol Accepted treatment

Haloperidol 10mg TAB Serenace Accepted treatment

Haloperidol 5mg TAB Serenace Sandoz Haloperidol Accepted treatment

Risperidone 0.5mg TAB DRL-Risperidone Risperidone-Hexal Mylan-Risperidone Motivation required

Risperidone 1mg TAB DRL-Risperidone Risperidone-Hexal Mylan-Risperidone Motivation required

Risperidone 2mg TAB DRL-Risperidone Risperidone-Hexal Mylan-Risperidone Motivation required

Risperidone 3mg TAB DRL-Risperidone Risperidone-Hexal Perizal Motivation required

Risperidone 4mg TAB Aspen Risperidone Risponz Motivation required

Trifluoperazine 1mg TAB Stelazine Accepted treatment

Trifluoperazine 5mg TAB Stelazine Accepted treatment

Zuclopenthixole 10mg TAB Clopixol Motivation required

Zuclopenthixole 2mg TAB Clopixol Motivation required

Spinal cord injuries

Antipropulsives

Loperamide 2mg TAB/CAP Adco loperamide Gastron Imodium Accepted treatment

Loperamide 1mg/5ml SYR Adco loperamide Imodium Accepted treatment

Laxatives

Bisacodyl 5mg TAB Dulcolax Accepted treatment

Glycerol SYR / SUP Glycerine Accepted treatment

Ispaghula and combinations GRA / SAC Fybogel Agiolax Accepted treatment

Lactulose 3.3g/5ml SYR Duphalac Aculax Adco-liquilax Accepted treatment

Lactulose SAC Duphalac dry Laxette dry Accepted treatment

Senna glycosides and combinations

TAB / GRA Senokot Soflax Accepted treatment

Heterocyclic Antidepressants

Amitriptyline 10mg TAB Trepiline Accepted treatment

Amitriptyline 25mg TAB Trepiline Sandoz-amitriptyline Accepted treatment

Muscle Relaxants

Baclofen 10mg TAB Bio-baclofen Accepted treatment

Baclofen 25mg TAB Lioresal Motivation required

Orphenadrine 100mg TAB Norflex Accepted treatment

Antibiotics, oral

Nitrofurantoin 50mg CAP Macrodantin Accepted treatment

Page 45: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

45

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Nitrofurantoin 100mg CAP Macrodantin Accepted treatment

Stroke

Aspirin

Acetylsalicylic acid 100mg TAB Bayer Aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-Aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf Aspirin Be-tabs aspirin Aspirin (resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment in children

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Anticoagulants

Warfarin 1mg TAB Cipla-warfarin Accepted treatment

Warfarin 3mg TAB Cipla-warfarin Accepted treatment

Warfarin 5mg TAB Cipla-warfarin Lennon warfarin Accepted treatment

Thalassemia

Supplemments

Folic acid 0.5mg TAB Folic Acid Accepted treatment

Chelating agents

Deferasirox 125mg DSP Exjade Special investigation

Deferasirox 250mg DSP Exjade Special investigation

Deferasirox 500mg DSP Exjade Special Investigation

Deferoxamine 500mg INJ Desferal Special investigation

Thromboembolic disease

Aspirin

Acetylsalicylic acid 100mg TAB Bayer Aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-Aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf Aspirin Be-tabs aspirin Aspirin (resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment in children

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Anticoagulants

Warfarin 1mg TAB Cipla-warfarin Accepted treatment

Warfarin 3mg TAB Cipla-warfarin Accepted treatment

Warfarin 5mg TAB Cipla-warfarin Lennon warfarin Accepted treatment

Page 46: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

46

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Transient Ischaemic Attack

Aspirin

Acetylsalicylic acid 100mg TAB Bayer Aspirin cardio Disprin CV Myoprin Accepted treatment

Acetylsalicylic acid 125mg TAB Lo-Aspirin Accepted treatment

Acetylsalicylic acid 300mg TAB Gulf Aspirin Be-tabs aspirin Aspirin (resmed) Accepted treatment

Acetylsalicylic acid 60mg TAB Genpharma Children Aspirin Accepted treatment in children

Acetylsalicylic acid 81mg ECT Ecotrin Accepted treatment

Anticoagulants

Warfarin 1mg TAB Cipla-warfarin Accepted treatment

Warfarin 3mg TAB Cipla-warfarin Accepted treatment

Warfarin 5mg TAB Cipla-warfarin Lennon warfarin Accepted treatment

Tuberculosis

Drugs

Ethambutol 400mg TAB Sandoz ethambutol Special investigations

Isoniazid 100mg TAB Be-tabs Isoniazid Special investigations (also prophylaxis)

Pyrazinamide 500mg TAB Sandoz Pyrazinamide Special investigations

Rifampicin 450mg TAB Rimactane Special investigations

Rifampicin 600mg TAB Rimactane Special investigations

Rifampicin 150mg CAP Rimactane Special investigations

Rifampicin 300mg CAP Rimactane Special investigations

Rifampicin 100mg/5ml SUS R-cin Special investigations

Rifampicin & isoniazid 150/75mg TAB Rimactazid Special investigations

Rifampicin & isoniazid 300/150mg TAB Rimactazid Special investigations

Rifampicin & isoniazid 60/30mg TAB Rimactazid Paed Special investigations

Rifampicin, isoniazid & pyrazinamide

60/30/150mg TAB Rimcure Paed 3 FDC Special investigations

Rifampicin, isoniazid, pyrazinamide & ethambutol

150/75/400/275mg TAB Rifafour E- 275 Rimstar 4 -FDC Special investigations

Streptomycin 1g/3ml INJ Bio-strep Special investigations

Pyridoxine 25mg TAB Pyridoxine Be-tabs Pyridoxine Accepted treatment

Pyrazinamide 500mg TAB Sandoz Pyrazinamide Special investigations

Ethambutol 400mg TAB Sandoz ethambutol Special investigations

Ethionamide 250mg TAB Ethatyl Special investigations

Ofloxacin 200mg TAB Zanocin Tafloc Special investigations

Page 47: CHRONIC MEDICATION CORE FORMULARY Effective 1 January …

47

INGREDIENT STRENGTH DOSAGE FORM Example 1 Example 2 Example 3 COMMENT

Ofloxacin 400mg TAB Zanocin Tafloc Special investigations

Ciprofloxacin 250mg TAB Ciplox Special investigations

Ciprofloxacin 500mg TAB Ciplox Special investigations

Kanamycin 1g/3ml INJ Bio-kanamycin Special investigations

Amikacin 100mg INJ Amikacin-fresenius Special investigations

Amikacin 250mg INJ Amikacin-fresenius Special investigations

Amikacin 500mg INJ Amikacin-fresenius Special investigations

Amikacin 1000mg INJ Amikacin-fresenius Special investigations

Terizidone 250mg CAP Terivalidin Special investigations

Cycloserine 250mg CAP Aspen Cycloserine Special investigations

Tuberculoid Leprosy

Rifampicin 450mg TAB Rimactane Special Investigation

Rifampicin 600mg TAB Rimactane Special Investigation

Rifampicin 150mg CAP Rimactane Special Investigation

Rifampicin 300mg CAP Rimactane Special Investigation

Rifampicin 450mg TAB Rimactane Special Investigation

Dapsone 100mg TAB Dapsone Special Investigation

Valvular heart disease

Antibiotics

Benzylpenicillin INJ Bio-pen Accepted treatment

Phenoxymethylpenicillin 250mg TAB Betapen Pen VK Accepted treatment

Erythromycin 250mg CAP Adco-erythromycin Betamycin Accepted treatment